Tsuneharu Baba

1.4k total citations
40 papers, 824 citations indexed

About

Tsuneharu Baba is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Tsuneharu Baba has authored 40 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Cardiology and Cardiovascular Medicine and 9 papers in Molecular Biology. Recurrent topics in Tsuneharu Baba's work include Blood Pressure and Hypertension Studies (12 papers), Diabetes Treatment and Management (7 papers) and Chronic Kidney Disease and Diabetes (6 papers). Tsuneharu Baba is often cited by papers focused on Blood Pressure and Hypertension Studies (12 papers), Diabetes Treatment and Management (7 papers) and Chronic Kidney Disease and Diabetes (6 papers). Tsuneharu Baba collaborates with scholars based in Japan, Germany and United States. Tsuneharu Baba's co-authors include Kazuo Takebe, Takashi Ishizaki, Peter Rossing, Takeshi Sugaya, Stine E. Nielsen, Peter Hovind, Hans‐Henrik Parving, Teruo Nakamura, Tsuyoshi Watanabe and Sabine Neugebauer and has published in prestigious journals such as Diabetes Care, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Tsuneharu Baba

39 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsuneharu Baba Japan 18 358 265 252 141 133 40 824
Anna Morocutti United Kingdom 17 384 1.1× 223 0.8× 236 0.9× 163 1.2× 209 1.6× 31 1.1k
Ole Wirta Finland 18 180 0.5× 234 0.9× 269 1.1× 138 1.0× 115 0.9× 30 896
E. Vittinghus Denmark 15 427 1.2× 281 1.1× 585 2.3× 187 1.3× 146 1.1× 24 1.3k
Johan Fagerudd Finland 18 670 1.9× 448 1.7× 236 0.9× 218 1.5× 189 1.4× 24 1.5k
Erik J.M. van Bommel Netherlands 9 712 2.0× 131 0.5× 432 1.7× 131 0.9× 298 2.2× 19 1.2k
Tonny Jensen Denmark 19 800 2.2× 440 1.7× 345 1.4× 161 1.1× 138 1.0× 47 1.5k
Nigel Wheeldon United Kingdom 18 370 1.0× 1.1k 4.0× 233 0.9× 106 0.8× 142 1.1× 40 1.6k
Belinda Spoto Italy 18 261 0.7× 266 1.0× 397 1.6× 222 1.6× 190 1.4× 39 1.1k
P. Aa. Svendsen Denmark 10 698 1.9× 351 1.3× 724 2.9× 159 1.1× 126 0.9× 12 1.4k
Priscilla Zia United States 15 218 0.6× 122 0.5× 188 0.7× 151 1.1× 199 1.5× 22 1.2k

Countries citing papers authored by Tsuneharu Baba

Since Specialization
Citations

This map shows the geographic impact of Tsuneharu Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuneharu Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuneharu Baba more than expected).

Fields of papers citing papers by Tsuneharu Baba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuneharu Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuneharu Baba. The network helps show where Tsuneharu Baba may publish in the future.

Co-authorship network of co-authors of Tsuneharu Baba

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuneharu Baba. A scholar is included among the top collaborators of Tsuneharu Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuneharu Baba. Tsuneharu Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanada, Hironobu, Sanae Midorikawa, Junichi Yatabe, et al.. (2005). Elevation of Serum Soluble E- and P-Selectin in Patients with Hypertension Is Reversed by Benidipine, a Long-Acting Calcium Channel Blocker. Hypertension Research. 28(11). 871–878. 21 indexed citations
2.
Shimada, Koji, Tsuneharu Baba, Sabine Neugebauer, et al.. (2002). Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy. Journal of Diabetes and its Complications. 16(6). 386–390. 22 indexed citations
3.
Makita, Yuichiro, Toshihide Shike, Tomohito Gohda, et al.. (1999). Relationship between Polymorphism in the Angiotensinogen, Angiotensin-Converting Enzyme or Angiotensin II Receptor and Renal Progression in Japanese NIDDM Patients. ˜The œNephron journals/Nephron journals. 82(2). 139–144. 52 indexed citations
4.
Baba, Tsuneharu, Sho Nakajima, & Yoshitada Yajima. (1998). β3-Adrenergic Receptor Gene Polymorphism is not Associated with Hypertension in NIDDM Patients without Nephropathy. Hormone and Metabolic Research. 30(10). 629–632. 9 indexed citations
5.
Baba, Tsuneharu, Sabine Neugebauer, & Tsuyoshi Watanabe. (1997). Diabetic Nephropathy. Drugs. 54(2). 197–234. 11 indexed citations
6.
Baba, Tsuneharu, Lutz Heinemann, Maximus Berger, & P. T. Sawicki. (1995). Effect of 4-Hour Hyperglycaemia and Hyperinsulinaemia on Plasma Atrial Natriuretic Factor Concentrations. Hormone and Metabolic Research. 27(2). 95–99. 2 indexed citations
7.
Neugebauer, Sabine, Tsuneharu Baba, Tsuyoshi Watanabe, Takashi Ishizaki, & Kazuo Kurokawa. (1994). The N‐acetyltransferase (NAT) Gene: An Early Risk Marker for Diabetic Nephropathy in Japanese Type 2 Diabetic Patients?. Diabetic Medicine. 11(8). 783–788. 11 indexed citations
8.
Nakamura, Teruo, et al.. (1994). Altered Postprandial Insulin Requirement in IDDM Patients With Gastroparesis. Diabetes Care. 17(8). 901–903. 72 indexed citations
9.
Baba, Tsuneharu, T Kodama, & Takashi Ishizaki. (1993). Effect of chronic treatment with enalapril on glucose tolerance and serum insulin in non-insulin-resistant Japanese patients with essential hypertension. European Journal of Clinical Pharmacology. 45(1). 23–27. 11 indexed citations
10.
Fujita, Noriko, et al.. (1992). Hyperinsulinaemia and blood pressure in patients with insulinoma.. BMJ. 304(6835). 1157–1157. 18 indexed citations
11.
Kodama, Takahiro, et al.. (1992). Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria. Journal of Diabetes and its Complications. 6(2). 70–76. 3 indexed citations
12.
Baba, Tsuneharu, et al.. (1990). Renal effects of nicardipine, a calcium antagonist, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy. European Journal of Clinical Pharmacology. 38(5). 425–429. 13 indexed citations
13.
Baba, Tsuneharu, et al.. (1990). Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension. European Journal of Clinical Pharmacology. 38(3). 305–307. 2 indexed citations
14.
Sawicki, P. T., et al.. (1990). Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?. Diabetologia. 33(2). 121–124. 18 indexed citations
16.
Tamasawa, Naoki, et al.. (1988). Spontaneous remission of acromegaly after pituitary apoplexy following head trauma. Journal of Endocrinological Investigation. 11(6). 429–432. 25 indexed citations
17.
Ishizaki, Takashi, et al.. (1988). Effect of Cimetidine on the Pharmacokinetics and Pharmacodynamics of Enalapril in Normal Volunteers. Journal of Cardiovascular Pharmacology. 12(5). 512–519. 11 indexed citations
19.
Sasaki, Kazuo, et al.. (1983). Hormonal response to insulin-induced hypoglycemia in patients with Shy-Drager syndrome. Metabolism. 32(10). 977–981. 3 indexed citations
20.
Baba, Tsuneharu, et al.. (1983). Renin-angiotensin system and plasma aldosterone in Cushing's syndrome.. Endocrinologia Japonica. 30(6). 715–721.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026